Cefamp-T 1.125 Injection
Marketer
Zenstar Life Sciences
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Cefamp-T 1.125 Injection
Cefamp-T 1.125 Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism halts microbial proliferation, thereby curbing infection spread. Administration must be under a doctor's direct guidance; strict adherence to the prescribed schedule is crucial. Completing the full treatment course is vital, even with symptom improvement, as premature cessation can compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical consultation. Allergic reactions (skin rashes, pruritus, edema, dyspnea) demand prompt medical attention. Prior to commencing treatment, disclose all current medications and pre-existing health conditions to your physician. Pregnant or lactating individuals require specific medical advice before use. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing to driving ability, sedation or dizziness warrants driving cessation. Adequate rest, a balanced diet, and ample hydration promote faster recovery. Your physician may order lab tests and imaging to monitor treatment response.
Uses of Cefamp-T 1.125 Injection
Infections caused by bacteria
Major Benefits of Cefamp-T 1.125 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Cefamp-T 1.125 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cefamp-T 1.125 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Cefamp-T 1.125 Injection works:
Ceftriaxone and Tazobactum, combined as Cefamp-T 1.125 Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, an antibiotic, disrupts bacterial cell wall synthesis, thereby hindering bacterial survival. Tazobactum, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thus augmenting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with concurrent alcohol and Cefamp-T 1.125 Injection use.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefamp-T 1.125 is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or absent harm to the fetus; nevertheless, clinical data from human studies are scarce.
Breast feedingCAUTION
Administering Cefamp-T 1.125 Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the treatment period and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Cefamp-T 1.125 Injection can potentially reduce alertness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if any of these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Cefamp-T 1.125 Injection's use in individuals with renal impairment. Seek medical advice.
LiverCAUTION
Administering Cefamp-T 1.125 Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alterations for Cefamp-T 1.125 Injection are generally unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cefamp-T 1.125 Injection :
Omit a Cefamp-T 1.125 Injection dose? Seek medical advice immediately.
Facts to Know About Cefamp-T 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently